What is Integrated Diagnostics Holdings OCF Yield %?
Integrated Diagnostics HoldingsLSE:IDHC 58 OCF Yield % is 13.73 as of Jun. 29, 2026, which is 79% above its 10-year median of 7.67. GuruFocus rates LSE:IDHC with a GF Score™ of 58/100 and a GF Value™ of $0.57 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Integrated Diagnostics Holdings ranks better than 92.52% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Integrated Diagnostics Holdings's OCF Yield % or its related term are showing as below:
LSE:IDHC'
s OCF Yield % Range Over the Past 10 Years
Min: -1.79 Med: 7.67 Max: 28.79
Current: 13.73
During the past 13 years, the highest OCF Yield % of Integrated Diagnostics Holdings was 28.79%. The lowest was -1.79%. And the median was 7.67%.
LSE:IDHC's OCF Yield % is ranked better than 92.52% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.03
vs LSE:IDHC: 13.73
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Integrated Diagnostics Holdings OCF Yield % Related Terms
Integrated Diagnostics Holdings OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:IDHC vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrated Diagnostics Holdings OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Integrated Diagnostics Holdings's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrated Diagnostics Holdings (LSE:IDHC) has a OCF Yield % of 13.73 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Integrated Diagnostics Holdings and its competitors. This is 79% above median its historical median of 7.67. According to the industry distribution chart, Integrated Diagnostics Holdings ranks #16 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 7.5%.
Is Integrated Diagnostics Holdings' OCF Yield % too high?
Integrated Diagnostics Holdings' current OCF Yield % of 13.73 is 79% above median its 10-year median of 7.67. The Medical Diagnostics & Research industry median OCF Yield % is 1.03. Integrated Diagnostics Holdings' value of 13.73 is 1233% above this industry median. Based on the distribution chart, Integrated Diagnostics Holdings ranks #16 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Integrated Diagnostics Holdings has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integrated Diagnostics Holdings' OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integrated Diagnostics Holdings ranks #16 out of 214 companies for OCF Yield %. This places Integrated Diagnostics Holdings in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.03. Integrated Diagnostics Holdings' value of 13.73 is 1233% above this benchmark. While the company's 10-year median is 7.67 vs. the industry median of 1.03, Integrated Diagnostics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.03, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrated Diagnostics Holdings's current OCF Yield % of 13.73 is 1233% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Integrated Diagnostics Holdings and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrated Diagnostics Holdings's current OCF Yield % is 13.73, which is 79% above median its own 10-year median of 7.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings (LSE:IDHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.57, compared to a current price of $0.50 — trading 11.9% below its estimated fair value. The current OCF Yield % is 13.73, which is 79% above median its 10-year median of 7.67 and 1233% above the Medical Diagnostics & Research industry median of 1.03. Integrated Diagnostics Holdings' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Integrated Diagnostics Holdings (LSE:IDHC), the current OCF Yield % is 13.73 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrated Diagnostics Holdings (LSE:IDHC) Overvalued in 2026?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued.
The current stock price of $0.50 is trading 11.9% below its estimated GF Value™ of $0.57.
GuruFocus considers Integrated Diagnostics Holdings to be Modestly Undervalued.
Key valuation signals for LSE:IDHC:
OCF Yield %: 13.73 (79% above median its 10-year median of 7.67)
GF Value™: $0.57 vs. price of $0.50 (11.9% below fair value)
Industry Position: 1233% above the Medical Diagnostics & Research median (#16 of 214)
No single metric tells the full story. See the LSE:IDHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrated Diagnostics Holdings Business Description
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
58GF Score
Get the complete analysis for LSE:IDHC
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IDHC has been successfully added to your 
